FDA Renews EUA for Convalescent Plasma & Issues Cease & Desist for Unapproved Drugs & Covid Tests ...Middle East

Washington, DC…The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA has reissued the August 23, 2020 emergency use authorization (EUA) for the emergency use of COVID-19 convalescent plasma for the treatment of hospitalized patients with COVID-19. The Letter of Authorization has been revised to add the Mount Sinai COVID-19 ELISA IgG Antibody Test as an acceptable test to be used for the purpose of qualifying high and low titer COVID-19 convalescent plasma in the manufacture of COVID-19 convalescent plasma. As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly

Hence then, the article about fda renews eua for convalescent plasma issues cease desist for unapproved drugs covid tests was published today ( Wednesday 02/12/2020 - 09:15 PM ) and is available on Thepintree.net ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Renews EUA for Convalescent Plasma & Issues Cease & Desist for Unapproved Drugs & Covid Tests )

Also on site :

• Wharton’s great contrarian says AI adoption isn’t an easy way to cut headcount: ‘The key thing … is just how much work is involved in doing it’
• Shopkeepers, who traditionally support Iran’s regime, sparked the protests. Here’s why that’s significant
• ‘Something you would dream of’: Livermore snaps 121-game EBAL losing streak with win over Amador Valley